Literature DB >> 26834851

Molecular biology of gynecological cancer.

Kenzo Sonoda1.   

Abstract

Cancer is a pathological condition in which the balance between cell growth and death is disordered. Various molecules have been reported to be involved in the oncogenic process of invasion, metastasis and resistance to treatment. An exponential growth in the collection of genomic and proteomic data in the past 20 years has provided major advances in understanding the molecular mechanisms of human cancer, which has been applied to diagnostic and treatment strategies. Targeted therapies have been developed and adopted, particularly for advanced, refractory or recurrent cancers, depending on individual molecular profiles. The aim of the present review is to provide a report of the current literature regarding the molecular biology of gynecological cancers.

Entities:  

Keywords:  angiogenesis; gynecological cancer; molecular biology; oncogenesis; targeted therapy

Year:  2015        PMID: 26834851      PMCID: PMC4727069          DOI: 10.3892/ol.2015.3862

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  130 in total

1.  Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.

Authors:  R Halperin; S Zehavi; L Habler; E Hadas; I Bukovsky; D Schneider
Journal:  Eur J Gynaecol Oncol       Date:  2001       Impact factor: 0.196

Review 2.  An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases.

Authors:  Boon Chin Heng; Dominique Aubel; Martin Fussenegger
Journal:  Biotechnol Adv       Date:  2013-08-30       Impact factor: 14.227

Review 3.  Molecular and pathologic aspects of endometrial carcinogenesis.

Authors:  Jonathan L Hecht; George L Mutter
Journal:  J Clin Oncol       Date:  2006-10-10       Impact factor: 44.544

Review 4.  The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis.

Authors:  Kenzo Sonoda; Shingo Miyamoto; Manabu Nakashima; Norio Wake
Journal:  Front Biosci       Date:  2008-01-01

5.  Oncosuppressor proteins of fragile sites are reduced in cervical cancer.

Authors:  Enrico Giarnieri; Nicola Zanesi; Arianna Bottoni; Mauro Alderisio; Ankica Lukic; Aldo Vecchione; Vincenzo Ziparo; Carlo Maria Croce; Rita Mancini
Journal:  Cancer Lett       Date:  2009-08-22       Impact factor: 8.679

Review 6.  Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.

Authors:  Frank Entschladen; Theodore L Drell; Kerstin Lang; Jan Joseph; Kurt S Zaenker
Journal:  Lancet Oncol       Date:  2004-04       Impact factor: 41.316

7.  Validation of HB-EGF and amphiregulin as targets for human cancer therapy.

Authors:  Fusanori Yotsumoto; Hiroshi Yagi; Satoshi O Suzuki; Eiji Oki; Hiroshi Tsujioka; Touru Hachisuga; Kenzo Sonoda; Tatsuhiko Kawarabayashi; Eisuke Mekada; Shingo Miyamoto
Journal:  Biochem Biophys Res Commun       Date:  2007-11-20       Impact factor: 3.575

8.  Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma.

Authors:  V Greger; N Debus; D Lohmann; W Höpping; E Passarge; B Horsthemke
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

9.  Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells.

Authors:  Limei Yan; Bei Lin; Lili Gao; Song Gao; Chuan Liu; Changzhi Wang; Yifei Wang; Shulan Zhang; Masao Iwamori
Journal:  Int J Mol Sci       Date:  2010-11-08       Impact factor: 5.923

10.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

View more
  7 in total

1.  Autotaxin is a novel molecular identifier of type I endometrial cancer.

Authors:  Antonio Mazzocca; Luca Maria Schönauer; Rosalba De Nola; Antonio Lippolis; Teresa Marrano; Matteo Loverro; Carlo Sabbà; Edoardo Di Naro
Journal:  Med Oncol       Date:  2018-10-29       Impact factor: 3.064

Review 2.  Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer.

Authors:  Ting-Tai Yen; Tian-Li Wang; Amanda N Fader; Ie-Ming Shih; Stéphanie Gaillard
Journal:  Int J Gynecol Pathol       Date:  2020-01       Impact factor: 3.326

Review 3.  Phytochemicals in Gynecological Cancer Prevention.

Authors:  Marta Woźniak; Rafał Krajewski; Sebastian Makuch; Siddarth Agrawal
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

Review 4.  Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.

Authors:  Vahideh Keyvani; Espanta Riahi; Meysam Yousefi; Seyed-Alireza Esmaeili; Rana Shafabakhsh; Amin Moradi Hasan-Abad; Maryam Mahjoubin-Tehran; Michael R Hamblin; Samaneh Mollazadeh; Hamed Mirzaei
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

5.  The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer.

Authors:  Oliviero Marinelli; Maria Beatrice Morelli; Daniela Annibali; Cristina Aguzzi; Laura Zeppa; Sandra Tuyaerts; Consuelo Amantini; Frédéric Amant; Benedetta Ferretti; Federica Maggi; Giorgio Santoni; Massimo Nabissi
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

6.  Biological Function of PD-L2 and Correlation With Overall Survival in Type II Endometrial Cancer.

Authors:  Oliviero Marinelli; Daniela Annibali; Maria Beatrice Morelli; Laura Zeppa; Sandra Tuyaerts; Cristina Aguzzi; Consuelo Amantini; Federica Maggi; Benedetta Ferretti; Giorgio Santoni; Frédéric Amant; Massimo Nabissi
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

Review 7.  p38β - MAPK11 and its role in female cancers.

Authors:  Periklis Katopodis; Rachel Kerslake; Athanasios Zikopoulos; Nefeli Beri; Vladimir Anikin
Journal:  J Ovarian Res       Date:  2021-06-26       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.